Absence of evidence is not evidence of absence.break/—Carl Sagan
If early melanomas can be detected by full-body skin examination (FBSE) and removed surgically, doesn't screening for skin cancer make sense? Then why shouldn't we recommend this approach for our patients? These questions summarize a common reaction to a recommendation by the US Preventive Service Task Force (USPSTF), an organization lauded for using an evidenced-based approach. In a recent update1,2 regarding skin cancer screening, the USPSTF concluded: “The current evidence is insufficient to assess the balance of benefits and harms of screening for skin cancer by primary care clinicians or by patient skin self-examination.”1(p18)
Federman DG, Concato J, Kirsner RS. Screening for Skin Cancer: Absence of Evidence. Arch Dermatol. 2009;145(8):926–927. doi:10.1001/archdermatol.2009.130
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: